Institute for Women's Health (IfWH)
Department of Women’s Cancer
- Breast Cancer Research Group
- Cancer Proteomics Laboratory
- Epigenetics in Cancer
Gynaecological Cancer Research Centre
- UK FOCSS
- Patient Care Research
- Pre-Invasive Disease
- Translational Research Laboratories
Director of the Institute for Women’s Health at UCL and Co-Director of
the Department of Health Policy Research Unit in Maternal Health and
Care, University of Oxford. I spent 100% of my time on academic
UK Familial Ovarian Cancer Screening Study (UK FOCSS)
Clinical Lead: Dr Adam Rosenthal
More than 4,000 women die from ovarian cancer in the UK each year. The disease is commonly diagnosed at a late stage when prognosis is poor.
Up to 10% of ovarian cancers can be attributed to an inherited genetic predisposition. Women at high risk of developing the disease can be identified from their family history of cancer, where certain types of cancers are seen in affected relatives (e.g. ovarian cancer, breast cancer). Currently, the only prevention strategy available for these women is surgery to remove the ovaries and fallopian tubes. However, many women are unwilling to undergo risk-reducing surgery.
The aim of this national trial is to find out whether screening tests can pick up ovarian cancer at an early stage, when treatment is more likely to be successful.
Professor Ian Jacobs Chief Investigator
Professor Usha Menon Co-Investigator
Dr James Mackay Co-Investigator
Dr Steve Skates Co-Investigator
Dr Adam Rosenthal Co-Investigator
Page last modified on 30 apr 13 21:27 by Vijay Devineni